Ligand id: 7541

Name: ixekizumab

Immunopharmacology Comments
Ixekizumab is an effective treatment option for psoriasis [3-4], with potential for patients with an inadequate response to anti-TNF therapies [2].
Immunopharmacology Disease
Disease X-Refs Comment References
Psoriatic arthritis Disease Ontology: DOID:9008
Phase 3 clinical candidate for PsA (see NCT02349295). 10
Psoriasis Disease Ontology: DOID:8893
Approved therapeutic for psoriasis and plaque psoriasis.